September 11, 2014 9:52 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
In a report published Thursday, Morgan Stanley analyst Simeon Gutman reiterated an Overweight rating on
Vitamin Shoppe Inc (NYSE: VSI), but removed the $49.00 price target.In the report, Morgan Stanley noted, “We are surprised at the timing of VSI CEO Tony Truesdale's retirement announcement. Besides being on the younger side of CEOs in our space (52), Mr.Truesdale has been among the most active from a strategic perspective, acquiring Super Supplements, entering the Canadian market,enhancing VSI's e-Commerce platform, opening franchises in Panama, and most recently going vertical by purchasing a supplement manufacturer. We view all of these moves as positives, particularly the Nutri-Force acquisition as they point to a stronger competitive position in the future.”Vitamin Shoppe closed on Wednesday at $40.95.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.